aspartic acid has been researched along with Gastrointestinal Stromal Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berner, JM; Bruland, ØS; Holm, R; Joensuu, H; Kristian, A; Malinen, E; Revheim, ME; Seierstad, T | 1 |
Bei, T; Boikos, S; Carney, JA; Ferrando, B; Matyakhina, L; Muchow, M; Pasini, B; Stratakis, CA | 1 |
2 other study(ies) available for aspartic acid and Gastrointestinal Stromal Neoplasm
Article | Year |
---|---|
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Aspartic Acid; Benzamides; Drug Administration Schedule; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Histidine; Humans; Imatinib Mesylate; Mice; Mice, Nude; Mutation, Missense; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Xenograft Model Antitumor Assays | 2013 |
Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect.
Topics: Aspartic Acid; Base Sequence; DNA Mutational Analysis; Female; Gastrointestinal Stromal Tumors; Germ-Line Mutation; Humans; Middle Aged; Neoplasms, Multiple Primary; Receptor, Platelet-Derived Growth Factor alpha; Valine | 2007 |